Kasper Rossing
Kasper Rossing
overlæge kardiologi, Rigshospitalet København Danmark
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease
DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ...
Molecular & cellular proteomics 9 (11), 2424-2437, 2010
Progression of nephropathy in type 2 diabetic patients
K Rossing, PK Christensen, P Hovind, L Tarnow, P Rossing, HH Parving
Kidney international 66 (4), 1596-1605, 2004
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes
P Hovind, L Tarnow, K Rossing, P Rossing, S Eising, N Larsen, C Binder, ...
Diabetes care 26 (4), 1258-1264, 2003
Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study
K Rossing, KJ Schjoedt, UM Smidt, F Boomsma, HH Parving
Diabetes care 28 (9), 2106-2112, 2005
Clinical proteomics: a need to define the field and to begin to set adequate standards
H Mischak, R Apweiler, RE Banks, M Conaway, J Coon, A Dominiczak, ...
PROTEOMICS–Clinical Applications 1 (2), 148-156, 2007
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
P Jacobsen, S Andersen, K Rossing, BR Jensen, HH Parving
Kidney international 63 (5), 1874-1880, 2003
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial
K Rossing, P Jacobsen, L Pietraszek, HH Parving
Diabetes care 26 (8), 2268-2274, 2003
Urinary proteomics in diabetes and CKD
K Rossing, H Mischak, M Dakna, P Zürbig, J Novak, BA Julian, DM Good, ...
Journal of the American Society of Nephrology 19 (7), 1283-1290, 2008
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria
K Rossing, KJ Schjoedt, BR Jensen, F Boomsma, HH Parving
Kidney international 68 (3), 1190-1198, 2005
Beneficial impact of spironolactone in diabetic nephropathy
KJ Schjoedt, K Rossing, TR Juhl, F Boomsma, P Rossing, L Tarnow, ...
Kidney international 68 (6), 2829-2836, 2005
Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study
K Rossing, PK Christensen, BR Jensen, HH Parving
Diabetes care 25 (1), 95-100, 2002
Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease
J Jantos-Siwy, E Schiffer, K Brand, G Schumann, K Rossing, C Delles, ...
Journal of proteome research 8 (1), 268-281, 2009
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
KJ Schjoedt, K Rossing, TR Juhl, F Boomsma, L Tarnow, P Rossing, ...
Kidney international 70 (3), 536-542, 2006
CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
JJ Coon, P Zürbig, M Dakna, AF Dominiczak, S Decramer, D Fliser, ...
Proteomics–Clinical Applications 2 (7‐8), 964-973, 2008
Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy
P Clausen, P Jacobsen, K Rossing, JS Jensen, HH Parving, ...
Diabetic Medicine 17 (9), 644-649, 2000
Unchanged incidence of diabetic nephropathy in IDDM patients
P Rossing, K Rossing, P Jacobsen, HH Parving
Diabetes 44 (7), 739-743, 1995
Dual blockade of the renin–angiotensin system in type 1 patients with diabetic nephropathy
P Jacobsen, S Andersen, K Rossing, BV Hansen, HH Parving
Nephrology Dialysis Transplantation 17 (6), 1019-1024, 2002
Pregnancy and progression of diabetic nephropathy
K Rossing, P Jacobsen, E Hommel, E Mathiesen, A Svenningsen, ...
Diabetologia 45, 36-41, 2002
Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns
K Rossing, H Mischak, HH Parving, PK Christensen, M Walden, ...
Kidney international 68 (1), 193-205, 2005
Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy
P Jacobsen, K Rossing, P Rossing, L Tarnow, C Mallet, O Poirier, ...
Kidney international 53 (4), 1002-1006, 1998
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20